Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$350.25 - $422.63 $494,202 - $596,330
1,411 Added 46.58%
4,440 $1.59 Million
Q2 2023

Aug 10, 2023

SELL
$359.49 - $486.4 $1.51 Million - $2.05 Million
-4,212 Reduced 58.17%
3,029 $1.15 Million
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $2.67 Million - $3.21 Million
6,372 Added 733.26%
7,241 $3.47 Million
Q4 2022

Feb 13, 2023

SELL
$351.71 - $456.01 $9.75 Million - $12.6 Million
-27,735 Reduced 96.96%
869 $365,000
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $6.64 Million - $9.06 Million
16,090 Added 128.58%
28,604 $11.9 Million
Q2 2022

Aug 19, 2022

SELL
$463.67 - $597.16 $1.02 Million - $1.31 Million
-2,191 Reduced 14.9%
12,514 $6.19 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $4.82 Million - $6.76 Million
9,186 Added 166.44%
14,705 $8.28 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $1.4 Million - $1.57 Million
1,980 Added 55.95%
5,519 $4.17 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $2.33 Million - $2.92 Million
3,539 New
3,539 $2.64 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $5.05 Million - $5.69 Million
-8,765 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $4.47 Million - $5.41 Million
8,164 Added 1358.4%
8,765 $5.01 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $1.51 Million - $1.9 Million
-2,959 Reduced 83.12%
601 $350,000
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $1.15 Million - $1.36 Million
-2,541 Reduced 41.65%
3,560 $1.84 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $2.04 Million - $3.01 Million
6,101 New
6,101 $2.76 Million
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $11.3 Million - $13.3 Million
-35,415 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $10.8 Million - $12.2 Million
35,415 New
35,415 $11.8 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.